Heyholder
‹ Disclosures

Report on Large Shareholdings

Xcell Therapeutics Inc.

AI summary · Not investment advice

Due to on-market trades by related parties, the stake of Lee Eui-il and related parties in Excel Therapeutics fell from 18.75% to 18.65%.

Stake

18.65%

Key facts

Reporting holder
Lee Eui-il
Previous stake
18.75%
Show Korean comments

Comments

No comments yet

Comments from shareholders will appear here.